Krensavage Asset Management, LLC Merck & Co., Inc. Transaction History

Krensavage Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $28.8 Million - $33.7 Million	-412,809 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $1.2 Million - $1.37 Million	-17,308 Reduced 4.02%	412,809 $34.3 Million
Q4 2018 Feb 15, 2019	BUY	$65.24 - $75.71 $8,415 - $9,766	129 Added 0.03%	430,117 $32.9 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $5.28 Million - $6.13 Million	-80,920 Reduced 15.84%	429,988 $31.4 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $260,758 - $306,636	-4,520 Reduced 0.88%	510,908 $36.2 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $1.87 Million - $2.2 Million	-36,826 Reduced 6.67%	515,428 $31.3 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $20 Million - $23.3 Million	392,788 Added 246.31%	552,254 $30.1 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $11.6 Million - $13.8 Million	-224,149 Reduced 58.43%	159,466 $8.97 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $22.5 Million - $24.2 Million	383,615	383,615 $24.6 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Krensavage Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Krensavage Asset Management, LLC with notifications on news.